Skip to content
OpenCapital
Get started

Catalyst Pharmaceutical CPRX Financing Cash Flow

Financing Cash Flow at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$6.4M-32.0%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$12.17M+448%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$4.23M+130%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$7.06M-95.0%
Scholar Rock logo
Scholar RockSRRK
$193.79M+4,548%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$59.06M-50.8%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K—
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%
Enterprise value$3.09B-4.1%
P/E17.4×-1.6×
P/S6.4×-0.6×

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0×0.0×
Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's financing cash flow?
Catalyst Pharmaceutical (CPRX) reported financing cash flow of -$12.87M in Q1 2026.
How has Catalyst Pharmaceutical's financing cash flow changed year-over-year?
Catalyst Pharmaceutical's financing cash flow decreased by 520.7% year-over-year, from $3.06M to -$12.87M.
What is the long-term trend for Catalyst Pharmaceutical's financing cash flow?
Over 4 years (2021 to 2025), Catalyst Pharmaceutical's financing cash flow has grown at a 20.2% compound annual growth rate (CAGR), from -$8.14M to -$16.99M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.